具有潜在疫苗价值的弓形虫新基因wx2，wx的筛选与鉴定
摘要
研究背景:
弓形虫是一种专性细胞内寄生的机会致病原虫,生活史复杂,涉及的组织器官多,可引起人兽共患的弓形虫病。其危害严重程度在再现疾病之中仅次于结核;孕妇感染弓形虫可引起流产、早产、畸胎、死胎,婴幼儿先天性弓形虫病,小儿智力障碍等,对人口素质和优生优育和计划生育有严重影响。近年来,弓形虫脑炎已成为艾滋病患者的主要死亡原因之一;也是器官移植患者死亡和精神病发病的主要原因之一。危害如此严重,诊断、治疗和预防却还存在很多问题亟需解决。治疗尚无十分理想的药物,采用的化学药物有治疗周期长,药物毒副作用大,不能根治等缺陷,加上至今还无一种药物能够杀灭包囊内的虫体,加之弓形虫的重复感染十分迅速,故虽经多方面的努力,弓形虫病仍未得以很好地遏制。因此,研制有效的新药和安全高效的弓形虫病疫苗,已成为人们的迫切要求,而廉价、安全、高效的疫苗无疑是最为经济、实用的防治措施。弓形虫病疫苗候选分子的筛选一直是研究中的瓶颈,也是研究的焦点和热点。本工作在前期研究的基础上进一步筛选、鉴定更有效的疫苗候选基因或药物分子靶标,制备核酸疫苗进行动物实验并阐明这个基因的功能、作用机制及其潜在的应用价值。
研究目的:
(1)通过制备具有保护性的单克隆抗体,筛选、鉴定弓形虫病疫苗的新的候选基因。
(2)构建该基因的DNA疫苗,观察其动物保护效果以及对宿主机体免疫系统的影响。
(3)应用RNA干扰技术,使获得的候选基因在转录后水平沉默,从而使其所表达的蛋白下降或者缺失,以期进一步阐明该基因的功能和作用机制,对该基因的应用前景进行评估,并希望得到弓形虫的减毒虫株,用于制备减毒活疫苗。
研究方法:
(1)应用杂交瘤技术获得抗弓形虫的单克隆抗体,体内外实验观察其保护性效果。以弓形虫单克隆抗体作为探针免疫筛选弓形虫速殖子cDNA文库,获得其对应的基因序列。经Blast(http://www.ncbi.nlm.nih.gov/BLAST和(http://www.toxodb.org/ToxoDB.html.)进行同源性比较,登录GenBank并获得新基因登录序列号。
(2)采用双色免疫荧光抗体定位和真核细胞内表达等方法对该基因编码的蛋白质进行鉴定,应用生物信息学对基因编码蛋白的B细胞表位、氨基酸序列、蛋白质结构等进行预测和同源性分析。
(3)以携带wx2基因的pBluescript7C3-C3质粒DNA为模板,通过PCR扩增基因wx2的ORF;以携带wx基因的pBluescript2B9-G1质粒DNA为模板,经PCR扩增获得wx基因的ORF,构建wx2和wx新基因的DNA疫苗并免疫昆明小鼠,观察小鼠死亡时间和检测实验动物的淋巴细胞转化率、脾细胞CD_4~*与CD_8~+淋巴细胞比值、IFN-γ、血清特异抗体等,以期阐明对机体免疫系统的影响。
(4)应用RNA干扰技术构建新基因wx2,wx逆病毒表达载体,与真核表达质粒pcDNA3-wx2,pcDNA3-wx一起,经脂质体共转染真核细胞观察体外表达效果;经电穿孔法导入弓形虫体内,获得体内能持续表达siRNA分子的可遗传的RNA干扰虫株。采用Western-blotting,RT-PCR,Northern-blotting等方法鉴定其蛋白质及mRNA水平变化效果;并对有基因沉默效果的干扰虫株进行动物感染实验,观察其的毒力变化;以研究减毒活疫苗的潜在价值。
研究结果:
(1)获得了两株抗弓形虫的单克隆抗体7C3-C3,289-G1,体外保护性实验提示能抑制弓形虫对宿主细胞的侵袭以及在宿主细胞内的繁殖,其细胞感染率分别为28%和32%,对照组为85.2%;50个HeLa细胞中纳虫泡内平均虫体数目为5.18±3.34与5.50±2.36,对照组为11.12±4.29。被动转移实验提示其能够延长RH株弓形虫攻击小鼠的生存时间(7.2±0.42和7.0±1.41d,对照组为5.0d),表明这两个单抗具有一定的抗弓形虫感染的保护力。
(2)通过免疫筛选弓形虫速殖子cDNA文库,获得了两个单抗所对应的基因序列,经同源性比对发现它们为新基因;GenBank的登录号为AY238892和AY208994。通过双色免疫荧光定位和体外表达以及生物信息学分析对两个新基因进行了鉴定,证明WX2为一新的功能膜分子,分子量为49kDa;WX为弓形虫60S核糖体L7蛋白,分子量为47kDa,位于胞质中。
(3)成功构建了新基因wx2,wx的真核表达质粒,作为DNA疫苗免疫动物显示pcDNA3-wx2与pcDNA3-wx能显著延长弓形虫RH株攻击感染的生存时间,分别达289.14±46.81h和284.29±47.30h,对照组仅存活176.4±1.98h和172±1.88h,而且攻击感染30天后疫苗接种组21只实验鼠中均有4只小鼠存活,显示其潜在的应用价值。对免疫鼠研究发现,pcDNA3-wx2能刺激机体产生较高水平的IFN-γ(P＜0.05);pcDNA3-wx2与pcDNA3-wx都能使宿主脾细胞CD_4~+/CD_8~+比值下降,及产生特异性抗体,与对照组相比,P值＜0.05;但抗体效价的高低与保护力的强弱并不平行;提示该DNA疫苗主要以CD_8~+的CTL细胞途径激发机体的抗弓形虫效应。
(4)成功构建了5个针对基因wx2,wx的干扰表达质粒,获得了2株部分沉默的RNA干扰虫株wx2b-i和wxB-i虫株。经过体外表达以及RT-PCR,Northern-blotting等鉴定,证实基因wx2,wx mRNA水平及蛋白质的表达均有部分下降。干扰虫株wx2b-i腹腔接种小鼠后其存活时间明显延长,平均存活时间为235.4±15.4h,阴性组C-i和野生型RH株组分别为161.2±11.98h与165.4±6.09h,统计学分析具有显著性差异,发病及死亡时间推迟,表明干扰株的毒力有所降低。
结论:
(1)抗弓形虫的单克隆抗体7C3-C3,289-G1对于弓形虫的感染具有一定的保护性,能抑制弓形虫对宿主细胞的侵袭以及在宿主细胞内的繁殖;被动转移实验提示能够延长RH株弓形虫攻击小鼠的生存时间。
(2)WX2为一新的弓形虫功能膜分子,分子量为49kDa;WX为弓形虫60S核糖体L7蛋白,分子量为47kDa,定位于胞质中。wx2,wx是两个较好的弓形虫疫苗候选分子。
(3)成功建立了含新基因wx2,wx的DNA疫苗,能显著延长弓形虫强毒(RH株)攻击感染动物的生存时间,显示其潜在应用价值。对宿主免疫系统的影响观察提示其主要以CD_8~+的CTL细胞途径激发机体的抗弓形虫效应。
(4)成功构建了5个针对基因wx2,wx的干扰表达载体,并获得了两株部分沉默的RNA干扰虫株wx2b-i、wxB-i,其中wx2b-i虫株的毒力有所降低,为进一步研究基因wx2,wx的功能与作用机制奠定了基础。
Background:
Toxoplasma gondii is an obligate intracellular protozoan parasite which could infect nearly all kinds of animals and birds and involve multiple host organs.The infection can result in toxoplasmosis.In humanbeings,severe disease in adults exists mainly in mmunosuppressed patients.Toxoplasmosis was regarded as an important recurring disease only second to tuberculosis which was seriously harmful to human heath.The infected pregnant woman could transmit the parasite to fetus through placenta,leading to abortion,stillbirth,neonatal deformety, mental symptoms and congenital toxoplasmosis of survival infants.It brought very serious effects on the eugenesis and family planning in our country.Recently,it was reported that Toxoplasma encephalitis is the most important manifestation and the main cause of death of in immunodeficiency individuals,such as AIDS patients et al.Furthermore, toxoplasmosis is also the main cause of death in the patients who received organ transplantation and is one of the main reasons of first-episode in schizophrenia and cryptogenic epilepsy patients.At present,there are still difficulties in prevention,diagnosis and treatment of the disease. Chemotherapy is not satisfactory because of the toxicity,need for long-term treatment and rapid re-infection by the parasite;moreover, there is no drug that can kill the encysted bradyzoites.As a result, toxoplasmosis has not been well controlled in the world.The development of cheap,safe and effective vaccines and new therapeutic drugs become priorities in the control of the disease.Therefore,the screening of good candidate molecules for the toxoplasmosis vaccine is not only a research bottleneck,but also a focus and hot point in the currently vaccine research.On the basis of the previous studies,we devoted ourselves to find and identify more effective vaccine candidate genes or drug target molecules,and then to produce DNA vaccines, illuminate the function and mechanism of the gene,as well as its potential value.
Objective:
(A)Through preparing new monoclonal antibodies that possessing protection effect against T.gondii,to find and identify new candidate genes for the vaccine of toxoplasmosis.
(B)Constructing the DNA vaccines corresponding to the genes screened before,and surveying their protection effect in animals and the mechanism of the effect.
(C)RNAi technique was used to silence the genes at the post-transcription level to make its expressed protein being loss or declined,so as to illuminate the function of the genes and evaluate the practical prospects of the genes and their DNA vaccine.
Methods:
(1)Monoclonal antibodies against Toxoplasma gondii were produced by hybridoma technology,and then their protective effect in vitro and in vivo experiments were evaluated.Using these monoclonal antibodies as probes to immunoscreen toxoplasmosis tachyzoite cDNA library,the corresponding gene sequences were obtained.Afterward the homology analysis was blast at websites:http://www.ncbi.nlm.nih.Gov /BLAST and(http://www.toxodb.Org/ToxoDB.html.)Login GenBank and accessible sequence were acquired.
(2)The encoded proteins were identified by immurlofluorescence microcopy and the expressions in eukaryotic cells.The B cell epitope, amino acid sequence and the structure of the proteins encoded by the genes were predicted and homology analysis(including Phylograrn tree and the homology blast)was performed by bioinformation methods.
(3)Using plasmid pBluescript 7C3-C3 in which wx2 gene was carried as the template in PCR to amplify the ORF of wx2,and plasmid pBluescript 2B9-G1 in which gene wx was carried as the template in PCR to amplify the ORF of wx,the DNA vaccines with eukaryotic expression vector of the two new genes were constructed.Protective experiments in animals were done and the survival time of challenged mice was observed.Lymphocyte transformation rate,CD_4~+ and CD_8~+ lymphocyte ratio of the spleen cells,IFN-γlevel and specific antibody in serum of the immunized animals were examined.
(4)RNAi expressed vectors with the new gene wx2 and wx as their targets were constructed.The effect of interference was observed by lipid-mediated transfection of eukaryotic cells in vitro.Plasmid was transfected into the toxoplasma cells by electroporation,so that the silent strains of toxoplasma in which siRNA molecules could be expressed continuously were produced.By Western-blotting,RT-PCR,Northern blotting et al,the interference effect was characterized,and these artificially produced toxoplasma can be used for further study.
Result
(1)Two monoclonal antibodies against Toxoplasma gondii 7C3-C3, 2B9-G1 were obtained.The protective tests in vitro showed that these proteins could inhibit the invasion and proliferation of T.gondii RH strain in HeLa cells.The cell infection rate was 28%and 32%respectively,and that of the control was 85.2%.The average number of T.gondii tachyzoite of in 50 HeLa cells was 5.18±3.34 and 5.50±2.36,while that of the control was 11.12±4.29.The passive transfer test indicated that these proteins significantly prolonged the survival time of the challenged mice(7.2±0.42days and 7.0±1.41days,while that of the control was 5.0 days).It was also shown that the two McAbs had certain protection ability against T.gondii infection.
(2)Through immunoscreening toxoplasma tachyzoite cDNA library, the gene sequences corresponding to these two monoclonal antibodies were obtained.The accessible numbers were AY238892 and AY208994 in GenBank.By immunofluorescence localization test,expression in vitro and bioinformatics analysis,it was demonstrated that WX2 was a new functional molecule on the membrane of T.gondii of which molecular weight was 49kDa,and WX was a 60S ribosomal L7 protein of T.gondii, a molecule in cytoplasm of which the molecular weight was 47kDa.
(3)The DNA vaccines of new genes wx2 and wx were constructed successfully.Protective experiments of DNA vaccines pcDNA3-wx2 and pcDNA3-wx in animals showed that the vaccines could significantly prolong the survival time of the mice challenged by virulent RH strains of Toxoplasma.Comparing with other toxoplasma vaccines against the virulent strains reported currently,the survival time is the longest.The average survival time was 289.14±46.81hours and 284.29±47.30hours respectively.Moreover,30 days after challenge,there were still four mice survived in each group.The study on the impact to the immune system indicated that,pcDNA3-wx2 vaccine could stimulate the animal to produce high level IFN-γ(149.8±24.53ng),both pcDNA3-wx and pcDNA3-wx2 could induce the decrease of the CD4~+/CD8~+ ratio and the production of the specific antibody in the experimental mice.However, the level of antibody titers did not parallel with the degree of protection. It indicated that these two DNA vaccines could stimulate the host resisting Toxoplasma mainly by the way of CD8~+CTL cells.
(4)Five interference expression vectors against Gene wx2,wx were constructed,and two partially silent strains T.gondii wx2b-i and wxB-i, were obtained.At the same time the virulence of wx2b-i partially reduced. It was confirmed that the mRNA and protein expression of wx2 and wx genes were partly reduced which were identified by the in vitro expression,RT-PCR and Northern blotting.
Conclusion:
(1)Monoclonal antibodies 7C3-C3 and 2B9-G1 have some protective effect against Toxoplasma gondii.They can inhibit the invasion of the parasite to host cells and the propagation of it in the host cell.The passive transfer experiments suggested that they could prolong survival time of the mice challenged by RH strain Toxoplasma gondii.
(2)WX2 is a new functional membrane molecule,with 49kDa molecular weight.WX is toxoplasmoa 60S ribosomal L7 protein,with 47kDa molecular weight in cytoplasm.So the corresponding genes wx2 and wx are good new candidates for DNA vaccine of T.gondii.
(3)The DNA vaccines of new genes wx2 and wx were constructed successfully.Protective experiments in animals showed that the vaccine could significantly prolong the survival time of the mice challenged with virulent RH strains of Toxoplasma,The time is longer than that acquired by the other DNA vaccines on current reports,which indicated their potential value.The immue mechanism is mainly by the way of CD8~+ CTL cell.
(4)Five interference expression vectors against Gene wx2,wx were constructed,and two partial silent strains wx2b-iand wxB-i were obtained. All these formed a foundation for further study on the function and mechanism of gene wx2,wx.
弓形虫是一种专性细胞内寄生的机会致病原虫,生活史复杂,涉及的组织器官多,可引起人兽共患的弓形虫病。其危害严重程度在再现疾病之中仅次于结核;孕妇感染弓形虫可引起流产、早产、畸胎、死胎,婴幼儿先天性弓形虫病,小儿智力障碍等,对人口素质和优生优育和计划生育有严重影响。近年来,弓形虫脑炎已成为艾滋病患者的主要死亡原因之一;也是器官移植患者死亡和精神病发病的主要原因之一。危害如此严重,诊断、治疗和预防却还存在很多问题亟需解决。治疗尚无十分理想的药物,采用的化学药物有治疗周期长,药物毒副作用大,不能根治等缺陷,加上至今还无一种药物能够杀灭包囊内的虫体,加之弓形虫的重复感染十分迅速,故虽经多方面的努力,弓形虫病仍未得以很好地遏制。因此,研制有效的新药和安全高效的弓形虫病疫苗,已成为人们的迫切要求,而廉价、安全、高效的疫苗无疑是最为经济、实用的防治措施。弓形虫病疫苗候选分子的筛选一直是研究中的瓶颈,也是研究的焦点和热点。本工作在前期研究的基础上进一步筛选、鉴定更有效的疫苗候选基因或药物分子靶标,制备核酸疫苗进行动物实验并阐明这个基因的功能、作用机制及其潜在的应用价值。
研究目的:
(1)通过制备具有保护性的单克隆抗体,筛选、鉴定弓形虫病疫苗的新的候选基因。
(2)构建该基因的DNA疫苗,观察其动物保护效果以及对宿主机体免疫系统的影响。
(3)应用RNA干扰技术,使获得的候选基因在转录后水平沉默,从而使其所表达的蛋白下降或者缺失,以期进一步阐明该基因的功能和作用机制,对该基因的应用前景进行评估,并希望得到弓形虫的减毒虫株,用于制备减毒活疫苗。
研究方法:
(1)应用杂交瘤技术获得抗弓形虫的单克隆抗体,体内外实验观察其保护性效果。以弓形虫单克隆抗体作为探针免疫筛选弓形虫速殖子cDNA文库,获得其对应的基因序列。经Blast(http://www.ncbi.nlm.nih.gov/BLAST和(http://www.toxodb.org/ToxoDB.html.)进行同源性比较,登录GenBank并获得新基因登录序列号。
(2)采用双色免疫荧光抗体定位和真核细胞内表达等方法对该基因编码的蛋白质进行鉴定,应用生物信息学对基因编码蛋白的B细胞表位、氨基酸序列、蛋白质结构等进行预测和同源性分析。
(3)以携带wx2基因的pBluescript7C3-C3质粒DNA为模板,通过PCR扩增基因wx2的ORF;以携带wx基因的pBluescript2B9-G1质粒DNA为模板,经PCR扩增获得wx基因的ORF,构建wx2和wx新基因的DNA疫苗并免疫昆明小鼠,观察小鼠死亡时间和检测实验动物的淋巴细胞转化率、脾细胞CD_4~*与CD_8~+淋巴细胞比值、IFN-γ、血清特异抗体等,以期阐明对机体免疫系统的影响。
(4)应用RNA干扰技术构建新基因wx2,wx逆病毒表达载体,与真核表达质粒pcDNA3-wx2,pcDNA3-wx一起,经脂质体共转染真核细胞观察体外表达效果;经电穿孔法导入弓形虫体内,获得体内能持续表达siRNA分子的可遗传的RNA干扰虫株。采用Western-blotting,RT-PCR,Northern-blotting等方法鉴定其蛋白质及mRNA水平变化效果;并对有基因沉默效果的干扰虫株进行动物感染实验,观察其的毒力变化;以研究减毒活疫苗的潜在价值。
研究结果:
(1)获得了两株抗弓形虫的单克隆抗体7C3-C3,289-G1,体外保护性实验提示能抑制弓形虫对宿主细胞的侵袭以及在宿主细胞内的繁殖,其细胞感染率分别为28%和32%,对照组为85.2%;50个HeLa细胞中纳虫泡内平均虫体数目为5.18±3.34与5.50±2.36,对照组为11.12±4.29。被动转移实验提示其能够延长RH株弓形虫攻击小鼠的生存时间(7.2±0.42和7.0±1.41d,对照组为5.0d),表明这两个单抗具有一定的抗弓形虫感染的保护力。
(2)通过免疫筛选弓形虫速殖子cDNA文库,获得了两个单抗所对应的基因序列,经同源性比对发现它们为新基因;GenBank的登录号为AY238892和AY208994。通过双色免疫荧光定位和体外表达以及生物信息学分析对两个新基因进行了鉴定,证明WX2为一新的功能膜分子,分子量为49kDa;WX为弓形虫60S核糖体L7蛋白,分子量为47kDa,位于胞质中。
(3)成功构建了新基因wx2,wx的真核表达质粒,作为DNA疫苗免疫动物显示pcDNA3-wx2与pcDNA3-wx能显著延长弓形虫RH株攻击感染的生存时间,分别达289.14±46.81h和284.29±47.30h,对照组仅存活176.4±1.98h和172±1.88h,而且攻击感染30天后疫苗接种组21只实验鼠中均有4只小鼠存活,显示其潜在的应用价值。对免疫鼠研究发现,pcDNA3-wx2能刺激机体产生较高水平的IFN-γ(P＜0.05);pcDNA3-wx2与pcDNA3-wx都能使宿主脾细胞CD_4~+/CD_8~+比值下降,及产生特异性抗体,与对照组相比,P值＜0.05;但抗体效价的高低与保护力的强弱并不平行;提示该DNA疫苗主要以CD_8~+的CTL细胞途径激发机体的抗弓形虫效应。
(4)成功构建了5个针对基因wx2,wx的干扰表达质粒,获得了2株部分沉默的RNA干扰虫株wx2b-i和wxB-i虫株。经过体外表达以及RT-PCR,Northern-blotting等鉴定,证实基因wx2,wx mRNA水平及蛋白质的表达均有部分下降。干扰虫株wx2b-i腹腔接种小鼠后其存活时间明显延长,平均存活时间为235.4±15.4h,阴性组C-i和野生型RH株组分别为161.2±11.98h与165.4±6.09h,统计学分析具有显著性差异,发病及死亡时间推迟,表明干扰株的毒力有所降低。
结论:
(1)抗弓形虫的单克隆抗体7C3-C3,289-G1对于弓形虫的感染具有一定的保护性,能抑制弓形虫对宿主细胞的侵袭以及在宿主细胞内的繁殖;被动转移实验提示能够延长RH株弓形虫攻击小鼠的生存时间。
(2)WX2为一新的弓形虫功能膜分子,分子量为49kDa;WX为弓形虫60S核糖体L7蛋白,分子量为47kDa,定位于胞质中。wx2,wx是两个较好的弓形虫疫苗候选分子。
(3)成功建立了含新基因wx2,wx的DNA疫苗,能显著延长弓形虫强毒(RH株)攻击感染动物的生存时间,显示其潜在应用价值。对宿主免疫系统的影响观察提示其主要以CD_8~+的CTL细胞途径激发机体的抗弓形虫效应。
(4)成功构建了5个针对基因wx2,wx的干扰表达载体,并获得了两株部分沉默的RNA干扰虫株wx2b-i、wxB-i,其中wx2b-i虫株的毒力有所降低,为进一步研究基因wx2,wx的功能与作用机制奠定了基础。
Background:
Toxoplasma gondii is an obligate intracellular protozoan parasite which could infect nearly all kinds of animals and birds and involve multiple host organs.The infection can result in toxoplasmosis.In humanbeings,severe disease in adults exists mainly in mmunosuppressed patients.Toxoplasmosis was regarded as an important recurring disease only second to tuberculosis which was seriously harmful to human heath.The infected pregnant woman could transmit the parasite to fetus through placenta,leading to abortion,stillbirth,neonatal deformety, mental symptoms and congenital toxoplasmosis of survival infants.It brought very serious effects on the eugenesis and family planning in our country.Recently,it was reported that Toxoplasma encephalitis is the most important manifestation and the main cause of death of in immunodeficiency individuals,such as AIDS patients et al.Furthermore, toxoplasmosis is also the main cause of death in the patients who received organ transplantation and is one of the main reasons of first-episode in schizophrenia and cryptogenic epilepsy patients.At present,there are still difficulties in prevention,diagnosis and treatment of the disease. Chemotherapy is not satisfactory because of the toxicity,need for long-term treatment and rapid re-infection by the parasite;moreover, there is no drug that can kill the encysted bradyzoites.As a result, toxoplasmosis has not been well controlled in the world.The development of cheap,safe and effective vaccines and new therapeutic drugs become priorities in the control of the disease.Therefore,the screening of good candidate molecules for the toxoplasmosis vaccine is not only a research bottleneck,but also a focus and hot point in the currently vaccine research.On the basis of the previous studies,we devoted ourselves to find and identify more effective vaccine candidate genes or drug target molecules,and then to produce DNA vaccines, illuminate the function and mechanism of the gene,as well as its potential value.
Objective:
(A)Through preparing new monoclonal antibodies that possessing protection effect against T.gondii,to find and identify new candidate genes for the vaccine of toxoplasmosis.
(B)Constructing the DNA vaccines corresponding to the genes screened before,and surveying their protection effect in animals and the mechanism of the effect.
(C)RNAi technique was used to silence the genes at the post-transcription level to make its expressed protein being loss or declined,so as to illuminate the function of the genes and evaluate the practical prospects of the genes and their DNA vaccine.
Methods:
(1)Monoclonal antibodies against Toxoplasma gondii were produced by hybridoma technology,and then their protective effect in vitro and in vivo experiments were evaluated.Using these monoclonal antibodies as probes to immunoscreen toxoplasmosis tachyzoite cDNA library,the corresponding gene sequences were obtained.Afterward the homology analysis was blast at websites:http://www.ncbi.nlm.nih.Gov /BLAST and(http://www.toxodb.Org/ToxoDB.html.)Login GenBank and accessible sequence were acquired.
(2)The encoded proteins were identified by immurlofluorescence microcopy and the expressions in eukaryotic cells.The B cell epitope, amino acid sequence and the structure of the proteins encoded by the genes were predicted and homology analysis(including Phylograrn tree and the homology blast)was performed by bioinformation methods.
(3)Using plasmid pBluescript 7C3-C3 in which wx2 gene was carried as the template in PCR to amplify the ORF of wx2,and plasmid pBluescript 2B9-G1 in which gene wx was carried as the template in PCR to amplify the ORF of wx,the DNA vaccines with eukaryotic expression vector of the two new genes were constructed.Protective experiments in animals were done and the survival time of challenged mice was observed.Lymphocyte transformation rate,CD_4~+ and CD_8~+ lymphocyte ratio of the spleen cells,IFN-γlevel and specific antibody in serum of the immunized animals were examined.
(4)RNAi expressed vectors with the new gene wx2 and wx as their targets were constructed.The effect of interference was observed by lipid-mediated transfection of eukaryotic cells in vitro.Plasmid was transfected into the toxoplasma cells by electroporation,so that the silent strains of toxoplasma in which siRNA molecules could be expressed continuously were produced.By Western-blotting,RT-PCR,Northern blotting et al,the interference effect was characterized,and these artificially produced toxoplasma can be used for further study.
Result
(1)Two monoclonal antibodies against Toxoplasma gondii 7C3-C3, 2B9-G1 were obtained.The protective tests in vitro showed that these proteins could inhibit the invasion and proliferation of T.gondii RH strain in HeLa cells.The cell infection rate was 28%and 32%respectively,and that of the control was 85.2%.The average number of T.gondii tachyzoite of in 50 HeLa cells was 5.18±3.34 and 5.50±2.36,while that of the control was 11.12±4.29.The passive transfer test indicated that these proteins significantly prolonged the survival time of the challenged mice(7.2±0.42days and 7.0±1.41days,while that of the control was 5.0 days).It was also shown that the two McAbs had certain protection ability against T.gondii infection.
(2)Through immunoscreening toxoplasma tachyzoite cDNA library, the gene sequences corresponding to these two monoclonal antibodies were obtained.The accessible numbers were AY238892 and AY208994 in GenBank.By immunofluorescence localization test,expression in vitro and bioinformatics analysis,it was demonstrated that WX2 was a new functional molecule on the membrane of T.gondii of which molecular weight was 49kDa,and WX was a 60S ribosomal L7 protein of T.gondii, a molecule in cytoplasm of which the molecular weight was 47kDa.
(3)The DNA vaccines of new genes wx2 and wx were constructed successfully.Protective experiments of DNA vaccines pcDNA3-wx2 and pcDNA3-wx in animals showed that the vaccines could significantly prolong the survival time of the mice challenged by virulent RH strains of Toxoplasma.Comparing with other toxoplasma vaccines against the virulent strains reported currently,the survival time is the longest.The average survival time was 289.14±46.81hours and 284.29±47.30hours respectively.Moreover,30 days after challenge,there were still four mice survived in each group.The study on the impact to the immune system indicated that,pcDNA3-wx2 vaccine could stimulate the animal to produce high level IFN-γ(149.8±24.53ng),both pcDNA3-wx and pcDNA3-wx2 could induce the decrease of the CD4~+/CD8~+ ratio and the production of the specific antibody in the experimental mice.However, the level of antibody titers did not parallel with the degree of protection. It indicated that these two DNA vaccines could stimulate the host resisting Toxoplasma mainly by the way of CD8~+CTL cells.
(4)Five interference expression vectors against Gene wx2,wx were constructed,and two partially silent strains T.gondii wx2b-i and wxB-i, were obtained.At the same time the virulence of wx2b-i partially reduced. It was confirmed that the mRNA and protein expression of wx2 and wx genes were partly reduced which were identified by the in vitro expression,RT-PCR and Northern blotting.
Conclusion:
(1)Monoclonal antibodies 7C3-C3 and 2B9-G1 have some protective effect against Toxoplasma gondii.They can inhibit the invasion of the parasite to host cells and the propagation of it in the host cell.The passive transfer experiments suggested that they could prolong survival time of the mice challenged by RH strain Toxoplasma gondii.
(2)WX2 is a new functional membrane molecule,with 49kDa molecular weight.WX is toxoplasmoa 60S ribosomal L7 protein,with 47kDa molecular weight in cytoplasm.So the corresponding genes wx2 and wx are good new candidates for DNA vaccine of T.gondii.
(3)The DNA vaccines of new genes wx2 and wx were constructed successfully.Protective experiments in animals showed that the vaccine could significantly prolong the survival time of the mice challenged with virulent RH strains of Toxoplasma,The time is longer than that acquired by the other DNA vaccines on current reports,which indicated their potential value.The immue mechanism is mainly by the way of CD8~+ CTL cell.
(4)Five interference expression vectors against Gene wx2,wx were constructed,and two partial silent strains wx2b-iand wxB-i were obtained. All these formed a foundation for further study on the function and mechanism of gene wx2,wx.
引文
[1]于恩庶.警惕新出现的人兽共患病.中国人兽共患病杂志,1997:13(5):3-5
[2]Luft BJ,Remington JS.Toxoplasmic encep Halitis in AIDS.ClinInfect Dis,1992,15(2):211-22
[3]Kasper LH,Buzoni-gatel D.Some opportunistic parasitic infectios in AIDS:candidiasis,cryptosporidiosis,toxoplasmosis.Paratitol Today,1998,14(4):150-156.
[4]Conrath J,Mouly-BandiniA,Collart F,et al.Toxoplasm gondii retino choroiditis after cardiac transplantation.Graefes Arch Clin Exp OpHthalmol,2003,241(4):334-8
[5]Mayes JT,OConnor BJ,Avery R,et al.Transmission of Toxoplasmagondii infection by liver transplantatiom Clin Infect Dis.1995,21(3):511-5
[6]AJ Cook,Gilbert RE,Buffolano W,et al.Sources of toxoplasma infection in pregnant women:European multicentre case-control study.European Research Network on Congenital Toxoplasmosis.BMJ.2000,321(7254):142-7
[7]Stommel EW,Seguin R,Thadani VM,SchwartzmanJD,Gilbert K,Ryan KA,Tosteson TD et al.Cryptogenic epilepsy:An infectious etiology?Epilepsia 2001,42:436-438
[8]YolkenRH,Bachmann S,Ruslanova I,Lillehoj E,Ford G,Torrey EF,Schroeder J.Antibodies to Toxoplasma gondii in individuals with firstepisode schizophrenia.Clin Infect Dis 2001,32:842-844 el
[9]Kouni MH.Adenosine metabolism in Toxoplasma gondii:Potential targets for chemotherapy.Curr PHarm Des 2007,13:581-597
[10]Smith AT,Tucker-Samaras SD,Fairlamb AH,Sullivan WJ Jr.MYST family histone acetytransferases in the protozoan parasite Toxoplasma gondii.Eukaryot Cell 2005,4:2057-2065
[11]Fiedler M,Horn C,Bandtlow C,et al.Anengineered IN-1 Fab fragment with improved affinity forth eNogo-Aaxonal growth inhibitor permits immunochemical detection and shows enhanced neutralizing activity.Protein Eng.2002,15,931-941.
[12]Yu JY,Taylor J,DeRuiter SL,et al.Simultaneous inhibition of GSK3alpHa and GS K3 beta usingh airpins RNAi expressionv ectors.MoL Ther,2003,7:228-236.
[13]Brosamle C,Huber AB,Fiedler M,Set al.Re-generation of lesioned corticospinal tract fibers in the adult rat in duced by a recombinant,humanized IN-1 antibody fragment.J.Neurosci.2000,20,8061-8068.
[14]Amarzguioui M,Holen T,Babaie E,etal.Tolerance for mutations and Chemical modifications in a siRNA.Nucleic Acids Res,2003,312589-595.
[15]章谷生 容秉培主编.单克隆抗体技术在医学中的应用.上海科学技术出版社 1987:13-14.
[16]Donald RG,Roos DS.Insertional mutagenesis and marker rescue in a protozoan parasite:Cloning of the uracil pHospHoribosyltransferase locus from Toxoplasma gondii.Proc Natl Acad Sci USA 1995,92:5749-5753
[17]Luo S,Marchesini N,Moreno SN,Docampo R.A plant-like vacuolar H+-pyropHospHatase in Plasmodium falciparum.FEBS Lett 1999,460:217-220
[18](美)萨姆布鲁克(sambrook,J)等著;黄培堂等译.分子克隆实验指南.第三版.北京:科学出版社,2002.8:96-98.
[19]Laemmli UK.Cleavage of structural proteins during the assembly of the head of bacteriopHage T4.Nature 1970,15:227:680-685.
[20]Hillier LD,Lennon G.,Becker M,Bonaldo MF,Chiapelli B,Chissoe S,Dietrich N et al.Generation and analysis of 280,000 human expressed sequence tags.Genome Res 1996,6:807-828
[21]Scheetz TE,Raymond MR,Nishimura DY,McClain A,Roberts C,Birkett C,Gardiner J et al.Generation of a high-density rat EST map.Genome Res 2001,11:497-502
[22]Marra MA,Kucaba TA,Hillier LW,Waterston RH.High-throughput plasmid DNA purification for 3 percents sample.Nucleic Acids Res 1999,27:e37
[23]Calvin Jungl,Cleo YF.Leel Michael,et al.The SRS superfamily of Toxoplasma surface proteins.International Journal for Parasitology 34(2004)285-296
[24]Gutierrez Escobar AJ,Gomez-Marin JE.Toxoplasma gondii:Identification of a putative nitric oxide synthase motif DNA sequence.Exp Parasitol 2005,111:211-218
[25]Ajioka JW,Boothroyd JC,Brunk BP,Hehl A,Hillier L,Manger ID,Marra M et al.Gene discovery by EST sequencing in Toxoplasma gondii reveals sequences restricted to the Apicomplexa.Genome Res 1998,8:18-28
[26]Escobar AJ,Arenas AF,Gomez-Marin JE.Molecular evolution of serine/arginine splicing factors family(SR)by positive selection.In Silico Biol 2006,6:347-350
[27]凌家俭,章子豪,张耀娟卫氏并殖吸虫成虫cDNA文库的单抗筛选[J].中国人兽共患病杂志,2002 18(3):48-51.
[28]Mercier E,Lecordier L,Darcy F,Deslee D,et al.Molecular characterization of a dense granule antigen(Gra 2)associated with the network of the parasitopHorous vacuole in Toxoplasma gondii[J].Mol Biochem Parasitol 1993;58(1):71-82
[29]Ahn H J,Kim S,Nam HW.Molecular cloning of the 82-kDa heat short protein(HSP90)of Toxoplasma gondii associated with the entry into and growth in host cells.Biochem BiopHys Res Commun 2003,311:654-659
[30]Ahn H J,Kim S,Nam HW.Molecular cloning of a rhoptry protein(ROP6)secreted from Toxoplasma gondii.Korean J Parasitol 2006,44:251-254
[31]M.F.CESBRON-DELAUW,B.Guyt,G.TORPIER,R.J.PIERCE,et al.Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii(cDNA cloning/Ca2+-binding protein).Proc.Natl.Acad.Sci.USA Vol.86,pp.7537-7541,October 198
[32]Parmley SF,Yang S,Harth G,et al.Molecular characterization of a 65-kilodalton Toxoplasma gondii antigen expressed abundantly in the matrix of tissue cysts J.Mol Biochem parasitol,1994,66(2):283-296.
[33]Nockemann S,Dlugonska H,Henrich B.Expression,characterization and serological reactivity of a 41kDa excreted-secreted antigen (ESA)from Toxoplasma gondii.[J].Mol Biochem parasitol,1998, 97(1-2):109-121.
[34]Ossorio PN,Schwartzman JD,Boothroyd JC.A Toxoplasma gondii rhoptry protein associated with host cell penetration has unusual charge asymmetry.Mol Biochem Parasitol 1992,50:1-15
[35]Kimberly L.Carey,Carolyn G.Donahue,Gary E.Ward.Identification and molecular characterization of GRA8,a novel,proline-rich,dense granule protein of Toxoplasma gondii_Molecular and Biochemical Parasitology 2000,105:25-37
[36]Bohne W,Gross U,Ferguson DJ,Heesemann J.Cloning and characterization of a bradyzoite-specifically expressed gene(hsp30/bag1)of Toxoplasma gondii,related to genes encoding small heat-shock proteins of plants.Mol Microbiol 1995,16:1221-1230
[37]Li L,Brunk BP,Kissinger JC,Pape D,Tang K,Cole RH,Martin J et al.Gene discovery in the apicomplexa as revealed by EST sequencing and assembly of a comparative gene database.Genome Res 2003,13:443-454
[38]Kami Kima B,Louis M.Weissa,C.Toxoplasma gondii:the model apicomplexan.International Journal for Parasitology,2004,34423-432.
[39]熊思东,徐薇.DNA疫苗的研究进展.中国处方药,2003,2:35237.
[40]Hoffman SL,Sedegah M,Hedstrom RC.Protection against malaria by immunization with a Plasmodium yoelii circumsporo zoite protein nucleic acid vaccine.Vaccine,1994,12(16):15292-1533
[41]Damo X,Lien FX.Genetic vaccination against leishmania.Vaccine,1994,12:1534-6.
[42]Angus CW.Nucleic acid vaccination against Toxoplasma gondii in mice.J Eudaryot Microbiol,1996,43(5):1172118.
[43]Xu D,Liew FY.Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein,gp63 of L.major.Immunology 1995,84:173-6.
[44]Rafati S,Salmanian AH,Taheri T,et al.A protective cocktail vaccine against murine cutaneous Leishmania major.Vaccine.2001,19:3369-75.
[45]Alberti E,Acosta A,Sarmiento ME.et al.Specific cellular and humoral immune response in BALB/c mice immunised with an expression genomic library of Trypanosoma cruzi.Vaccine.1998,16:608-12.
[46]Sepulveda P,Hontebeyrei M,Liegeard P,Mascilli A,Norris KA.DNA-based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection.Infect Immun 2000,68:4986-91.
[47]Amador EA,Acosta Dominguez A,Sarmineto ME,Hidalgo Grass C,Fachado Carvajales A,Vidal Martinez T,et al.Specific humoral response in BALB/c mice inoculated with genome library of expression of Trypanosoma cruzi.Rev Cuba Med Trop 1999;51:20-5.
[48]Mendez S,Gurunathan S,Kamhawai S,et al.The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose,intradermal challenge.J Immunol 2001;166:5122-8.
[49]Angus CW,Klivington-Evans D,Dubey JP,and Kovacs J A.Immunization with a DNA plasmid encoding the SAG1(P30)protein ofToxoplasma gondii is immunogenic and protective in rodents.J.Infect.Dis.2000,181:317-324.
[50]Nielsen HV,Lauemoller S L,Christiansen L,et al.Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene.Infect.Immun.1999.67:6358-6363.
[51]Beghetto,E.,A.Pucci,O.Minenkova,et al.Identification of a human immunodominant B-cell epitope within the GRA1 antigen of Toxoplasma gondii by pHage display of cDNA libraries.Int.J.Parasitol.2001.31:1659-1668.
[52]Cesbron-Delauw MF,Guy B,Torpier G,et al.Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii.Proc.Natl.Acad.Sci.USA 1989,86:7537-7541.
[53]Duquesne V,Auriault C,Gras-Masse H,et al.Identification of T cellepitopes within a 23-kD antigen(P24)of Toxoplasma gondii.Clin.Exp.Immunol.1991.84:527-534.
[54]Desolme B,M.N.Mevelec,D.Buzoni-Gatel,and D.Bout.Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene.Vaccine.2000, 18:2512-2521.
[55]Guo,H.,G.Chen,F.Lu,H.Chen,and H.Zheng.Immunity induced by DNA vaccine of plasmid encoding the rhoptry protein 1 gene combined with the genetic adjuvant of pcIFN-gamma against Toxoplasma gondii in mice.Chin.Med.J.(Engl.Ed.)2001,114:317-320.
[56]Leyva,R.,P.Herion,and R.Saavedra.Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii.Parasitol.Res.2001,87:70-79.
[57]Vercammen,M,Scorza T,Huygen K,De Braekeleer,Diet R,Jacobs D,Saman E,and Verschueren H.DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1,GRA7,and ROP2 induces partially protective immunity against lethal challenge in mice.Infect.Immun.2000,68:38-45.
[58]Angus CW,Clivington-Evans D,Dubey JP,et al.Nucleic acid vaccination against Toxoplasma gondii in mice.J.Eudaryot Microbiol,1996,43(5):117-118
[59]Nielsen HV,Lauemoller SL,Christiansen L,et al.Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene.InfectImmun,1999,67:635826363.
[60]Bout D.Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles:preparation,characterization,and preliminary i n vivo studies.Int J PHarmaceutics,2003,266(122):17227.
[61]Desolme B,Marie2Noelle M,Buzoni2Gatel D,et al.Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene.Vaccine,2000,18:251222521.
[62]Vercammen M,Scorza T,Huygen K,et al.DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1,GRA7 and ROP2 induces partially protective immunity against lethal challenge in mice.Infect Immun,2000,68:38245.
[63]Fachado A,Rodriguez A,Angel SO,et al.Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice.Vaccine,2003,21(13214):132721335.
[64]Mohamed RM,Aosai F,Chen M,et al.Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70,HSP30and SAG1 genes.Vaccine,2003,21(21222):285222861.
[65]Suzuki Y,Rani S,Oliver L.Imparied resistance to the development of Toxoplasmic:EncepHalitis in interleukin 6-deficient mice.[J]Induct Immun,1997,65(6):2339-2349
[66]Lloyol HK,Mastsuura T,Finseka S.Induction of γ δTcell during acute murine infection with Toxoplasma gondii.J Immunol,1996,157(12):5521-5527
[67]Nagasawa H,Hisaeda H,Maelawa Y,et al.Gama delta Tcells play crucial role in the expression of 65,000MW heat-shock protein in mice innunized with Toxoplasma antigen.J.Immunol,1994,83(3):347-352.
[68]Suzuki Y,Remington JS.The effect of anti-IFN-γ antibody in the protective effect of Lyt2+T cell against Toxoplasmasis in mice.J Immunol,1990,144(5):1954-1956
[69]Suzuki Y,Orellana MA,Sxhreiber RD.Interferon-gama:The major mediater of resistance against Toxoplasma gondii.Science,1988,240(4851):516-518.
[70]Suzuki Y,Conley FK,Remington JS.Importance of endogenacs IFN-γfor prevention of Toxoplasmic EncepHalitis in mice.J Immunol,1989,143(6):2045-2050.
[71]Donnelly JJ,Ulmer JB,Shiver JW,Liu MA.DNA vaccines.AnnuRev Immunol 1997,15:617-48.
[72]Stacey KJ,Blackwell JM.Immunostimulatory DNA as an adjuvantin vaccination against Leishmania major.Infect Immunol 1999,67:3719-26.
[73]Kowalczyk DW,Ertl HC.Immune responses to DNA vaccines.CellMol Life Sci 1999,55:751-70.
[74]Gazzinelli RT,Hakin FT,Hieny S,Shearer GMA,Sher A.Synergistic role of ED4+ and CD8+ T lympHocytes in IFN-gamma productionand protective immunity induced by an attenuated T.gondii vaccine.J Immunol 1991,146:286-92.
[75]Gazzinelli RT,Hieny S,Wynn TA,Wolf S,Sher A.Interleukin-12 is required for the T-lympHocyte-independent induction to interferon gamma by an intracellular parasite and induces resistance in T cell deficient host.Proc Natl Acad Sci USA 1993,90:6115-9.
[76]Todryk S,Melcher AA,Dalgleish AG,et al.Heat shock proteins refine the danger theory.Immunology 2000,99:334- 7.
[77]Tighe H,Corr M,Roman M,Raz E.Gene vaccination:plasmid DNA is more than just a blueprint.Immunol Today 1998,19(2):89-97.
[78]Kevin N.Couper,Henrik V.Nielsen,Eskild Petersen,Fiona Roberts,Craig W.Roberts,James Alexander.DNA vaccination with the immunodominant tachyzoite surface antigen(SAG-1)protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmissionVaccine 21(2003)2813-2820
[79]Nielsen HV,Lauemoller SL,Christiansen L,et al.Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG-1 gene.Infect Immun 1999,67:6358-63.
[80]Angus CW,Klivington-Evans D,Dubey JP,Kovacs JA.Immunization with a DNA plasmid encoding the SAG-1(P30)protein of Toxoplasma gondii is immunogenic and protective in rodents.J Infect Dis.2000;181:317 -24.
[81]Vercammen M,Scorza T,Huygen K,De Braekeleer J,Diet R,Jacobs D,et al.DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1,GRA7,and ROP2 induces partially protective immunity against lethal challenge in mice.Infect Immun.2000,68:38-45.
[82]Desolme B,Mevelec M-N,Buzoni-Gatel D,Bout D.Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene.Vaccine 2000,18:2512 -21.
[83]T.Scorza,S.D' Souza,M.Laloup,J.Dewit,J.De Braekeleer,H.Verschueren,M.Vercammen,K.Huygen,and E.Jongert.A GRA1 DNA Vaccine Primes Cytolytic CD8_ T Cells To Control Acute Toxoplasma gondii InfectionINFECTION AND IMMUNITY,Jan.2003,p.309-316
[84]Napoli C,Lemieux C,Jorgensen R.Introduction of achalcone synthase gene in to Petuinia results in reversible co-suppression of homologous genes in trans.Plant Cell,1990;2(4):2 79
[85]Fire A,Xu S,Montgmery MK,et at.Potent and specific geneticinterference by double-stranded RNA in Caenorhabditis elegans.Nature,1998,391:806-811.
[86]Guo S,KempHuesK J.Par-1,a genere quired for establishing polarity in C.elegans embryos,encodes a putative Ser/Thrkinase that is asymmetrically distributed.Cell,1995;81(4),611
[87]Beckebaum S,Cicinnati VR,Dworacki G,et al.Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DCI in chronic hepatitis B infection.Clin Immunol,2002,104(2):138-150
[88]Greenberg HB,Pollard RB,Lutwick LI,et al.Efect of human leukocyte Interferon on hepatitisB virusin fection in patients with chronic active hepatitis.N.EnglJ.Med,1976,295(10):517-522
[89]Wong DKH,Cheung AM,O'Rourke K,et al.Efect of alpHa-in-terferon Treatment in patients with hepatitis Be antigen-positivec hronich epatitisB.Ann Intern Med,1993,119:312
[90]Lin SM,Sheen IS,Chien RN,et al.Long-term beneficial dfect of interferon the rapyin patients with chronich epatitisB virusin fection.Hepatology,1999,29(3):971-975
[91]MosmannT R,CherwinskiH,BondM W,et al.Two types of murine helperT-cell Clone.I Definition according to profile so flymp-Hokine activities and secreted proteins.J Immunol,1986,136(7):2348-2357
[92]Niederau C,Heintges T,Lange S,et al.Long-term follow-up of HbeAg-positive Patients treated with interfereon alfa for chronich epatitisB.N EnglJ M ed,1996,334(22):1422-1427
[93]Torre D,Tambini R.In terferon-alpHath erapyfo rch ronich epatitis B in children:A meta-analysis.C linIn fectD is,1996,23(1):131-137
[94]Hadziyannis s S,B ramouT,M akris A,etal.In terferon alfa-2b treatment If HbeAg negative serum HBV DNA positive chronic activeh epatitsB.J Hepatol,1990,11(Supp 11):S133-S136
[95]Pastore G,Sa ntantonio T,M ilella A,et al.Anti-HBe-positive chronic hepatitisB with HBV-DNA in the serum:responesto a 6 month course of lympHoblastoidinterferon.Jhepatol,1992,14(2-3):221-225
[96]Cooksley WGE,Lai MY,Wang YJ,et al.HBeAg-positive chronic Hepatitis B (CHB) patients with difcult-to-treat disease: improved response rates with Peg interferonAlfa-2A (40KD) (PEGASYS) compared with conventional interferon Alfa-2a.Hepatology,2002,36(4) :374A
[97] Fattovichq Farci P; Rugge M, et al. Arandomized controlled trial of lympHobalastoid interferon-alfa in patients with chronic hepatitisB lacking HbeAg. Hepatology, 1992,15(4):584-589
[98] Lampertico P, DelN innoE, manzinA , et al .Arandomized, controlled trial of a 24-month couse of interferon alfa2b in patients with chronic hepatitisB who had Hepatitis B virusDNA without be patitisBe antigen in serum. Hepatology, 1997, 26(6): 1621—1625
[99] Cooksley WGE, Piratvisuth T, Lee SD, et al. Peginterferon a-2a (40kDa): an Advance in the treatment of hepatitis Be antigen-positive chronic hepatitisB .J Viral Hepat, 2003,10(4):298-305
[100] Thijn R. Brummel kamp, Rene Bernards, Reuven Agami1.A System for Stable Expression of Short Interfering RNAs in Mammalian Cells. SCIENCE 19 APRIL 2002, VOL 550: 296
[101] Thijn R. Brummelkamp, Rene Bernards, and Reuven Agami. Stable suppression of tumorigenicity by virus-mediated RNA interference. CANCER CELL AUGUST 2002,22.
[102] J. Y. Yu, S. L. Deruiter, D. L. Turner. RNA interference by expression of short -interfering RNAs and hairpin RNAs in mammalian cells. PNAS, 2002,99:6047-6052.
[103] Shen C, Buck A K, Liu X, et al. Gene silencing by adeovirus-delivered siRNA. FEBS, 2003, 539:111-114
[104] Ullu E, Tschudi C, Chakraborty T. RNA interference in protozoan parasites.Cell Microbiol. 2004.6, 509 - 519.
[105] Ahmad Al Riyahi, Fatme Al-Anouti, Marwan Al-Rayes, Sirinart AnanvoranichInternational Single argonaute protein from Toxoplasma gondii is involved in the double-tranded RNA induced gene silencing Journal for Parasitology. 2006, 36:1003-1014
[106] Al-Anouti F and Ananvoranich S. Comparative analysis of antisense RNA, double-stranded RNA, and delta ribozyme-mediated gene regulation in Toxoplasma gondii. Antisense Nucl Acid Drug. 2002,12:275-281.
[107] Al-Anouti, F., Quach, T. & Ananvoranich, S. Double-stranded RNA can mediate the suppression of uracil pHospHoribosyltransferase expression in Toxoplasma gondii.Biochem.BiopHys.Res.Commun.2003,02:316-323.
[108]Brian Adams,Alla Musiyenko,Rajinder Kumar,and Sailen Barik.A Novel Class of Dual-family ImmunopHilins J.Biol.Chem.,2005,280(26):24308-24314,July 1,
[109]Sirinart ananvoranich,Marian AL Rayes,Ahmad Al Riyahi and Xiang Wang.RNA Silencing of Glycolysis Pathway in Toroplasma gondii.Eukaryot.Microbiol.2006,3(S1),pp.S162-S163
[110]宋尔卫.DNA干扰的生物学原理与应用。北京:高等教育出版社.第一版.2005.1-30.
[111]G.J.汉农.RNAi基因沉默指南.北京:化学工业出版社.第一版.2004.86-105.
[112]Ute Schepers.实用RNAi技术-线虫、果蝇和哺乳动物细胞基因沉默的基本原则与方法.北京:人民卫生出版社.第一版.2006.58-78.
[113]Soldti D,Boothroyd JC.Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii.Science.1993,60(5106):349-52.
[114]Lindscry DS,Pinto DC,Yila I,et al.Safety and result of challenge of weaned pigs given a temperature sensitive mutant of Toxoma gondii.Parasitology.1993,79(1):71272.
[115]Gazzinelli RT,Hakim FT,Hieny S,et al.Synergistic role of CD4+ and CD8+T lympHocytes in IFN2c production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.J.Immunol.1991,146:2862292.
[116]O' connell E.Toxoplasmosis in sheep Ⅱ the ability of a live vaccine to prevent lamb losses after an intravenous challenge with Toxoplasma gondii.New Zealand Vet.J,1988,36:122.
[117]Buxton D,Innes E A.A commercial vaccine for ovine toxoplasmosis.Parasitology,1995,110(1):11216.
[1]Fire A,Xu S,Montgmery M K,et al.Potent and specific geneticinterference by double-stranded RNA in Caenorhabditis elegans.Nature,1998,391:806-811.
[2]Zamore PD,Tuschl T,Sharp PA,et al.RNAi:double stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals.Cel,2000,101(1):25-33.
[3]Kasschau KD,Carrington JC.A counterdefensive strate of plant viruses:uppression of posttranscriptional gene silencing.Cell,1998,95(4):461-470.
[4] Brigham PM. Cosuppression comes to the animals. Cell, 1997, 90(3): 385-387.
[5] Tuschl T, Zalnore PD, I_ehraann R, et al. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev, 199913(24): 3191—3197.
[6] Tavemarakis N, Wang S L, Domvkov M et al. Heritable and inducible genetic interference by double-stranded RNA encoded by trims genes. Nature Genetics, 2000; 24: 180-183.
[7] Lipardi C, Wei Q, Paterson BM RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. CAI, 2001,107: 297—307.
[8] Brummelkamp TR, Bernards R, Agni R. A system for stable expresion of short interfering RNAs in mammaliancells. Science, 2002,296(5 567): 550-553.
[9] Hutvagner G. Small RNA asymmetry in RNAi: Function in RISC assembly and gene regulation. FEBS Lett, 2005, [Epub ahead of print].
[10] Retting RF, Fischer SE, Bernstein E, et al. Dicer functionsin RNA interference and in synthesis of small RNA involved indevelopment altiming in C. elegans. Genes Dev, 2001,15(20): 2654-2 659.
[11] Harmon GJ. RNA interference. Nature, 2002, 418(6 894): 244-251.
[12] Meister G, Tuschi T. Mechanisms of gene silencing by double-stranded RNA. Nature, 2004, 431(7 006): 343—349.
[13] j wu Scharf D, Jeong B, Zhang C, et al. Transgene and transposon silencing in Chiamydomonas reinhardtii by a DEAH-box RNA helicase. Science, 2000, 290(5 494): 1159-1162.
[14] Melo CC, Conte D Jr. Revealing the world of RNA interference. Nature, 2001,4, 431(7 006): 338-342.
[15] David P. Knoxl, Peter Geldhof2, Aline Visser2 and Collette Britton.RNA interference in parasiticnematodes of animals: a reality check? TRENDS in Parasitology 2007, 23(3):105-107
[16] Ayman S. Hussein, Ketty Kichenin, Murray E. Selkirk. Suppression of secreted acetylcholinesterase expression inNippostrongylus brasiliensis by RNA interference . Molecular Biochemical Parasitology. 2002, 122: 91-94
[17] Aziz Aboobaker and Mark L Blaxter. Use of RNA interference to investigate gene function in the human filarial nematode parasite Brugia malayi.Mol Biochem Parasitology,2003,129(1):41-51
[18]Sara Lustigman,Jun Zhang,Jing Liu,Yelena Oksov and Sarwar Hashmi.RNA interference targeting cathepsin L and Z-like cysteine proteases of Onchocerca volvulus confirmed their essential function during L3 molting.Mol Biochem Parasitology,2004,138(2):165-170
[19]Patrick J.Skelly,Akram Da' dara,Donald A.Harn Suppression of cathepsin B expression in Schistosoma mansoni by RNAinterference.International Journal for Parasitology.2003,33:363-369
[20]Ahmed Osman,Edward G Niles,Sergio Verjovski-Almeida,and PHilip T,LoVerde.Schistosoma mansoni TGF-β Receptor Ⅱ:Role in Host Ligand-Induced Regulation of a Schistosome Target Gene.PLoS Pathog.2006,2(6):e54
[21]Yuemei Dong,Harry E Taylor,and George Dimopoulos.AgDscam,a Hypervariable Immunoglobulin Domain-Containing Receptor of the AnopHeles gambiae Innate Immune System.PLoS Biol.2006;4(7):229.
[22]Yuemei Dong,Ruth Aguilar,Zhiyong Xi,Emma Warr,Emmanuel Mongin2,George.DimopoulosAnopHeles gambiae Immune Responsesto Human and Rodent Plasmodium.Parasite Species.PLoS Pathog 2006,2(6):513-525
[23]Elisabetta Ullu,Christian Tschudi and Tirtha Chakraborty.RNA interference in protozoan parasites.Cellular Microbiology 2004,6(6):509-519
[24]Shi H,Djikeng A,Tschudi,C.,and Ullu,E.Argonaute protein in the early divergent eukaryote Trypanosoma brucei:control of small interfering RNA accumulation and retroposon transcript abundance.Mol Cell Biol 2004,24:420-427.
[25]Huynh TT,Huynh vT,Harmon MA,etal.Gene knockdown of gamma glutamylcysteine synthetase by RNAi in the parasitic protozoa Trypanosoma brucei demonstrates that it is an essential enzyme.J Biol Chem,2003,278(41):39794-39800.
[26]Wilkinson SR,Horn D,Prathalingam SR,et al.RNA interferenceidentifies two hydroperoxide metabolizing enzym es that are essential to the bloodstream form of the african trypanosome.J Biol Chem,2003,278(34): 31640—31646.
[27] Comini MA, Guerrero SA, Haile S, et al. Valdiation of Try. panosoma brucei trypanothione synthetase as drug target. Free Radic Biol Med, 2004, 36(10): 1289—1302.
[28] CoustouV, Besteiro S, Riviere L, et al. Amitochondrial NADH-dependent fumarate red uctase involved in the production of succinate excreted by procyclic Trypanosoma brucei. J Biol Chem, 2005,280(17): 16559— 16570
[29] Kesler PS, Parsons M、 Probing the role of compartmentation of glycolysis in procyclic forlTI Try panosoma bruce: RNA interference studies of PEX1, hexokinase, and pHospHofructokinase. J Biol Chem, 2005, 280(10): 9030—5036.
[30] Lamour N, Riviere L, Coustou V, et al、 Proline metabolism in procyclic Trypanosoma brucei is down regulated in the presence of glucose. J Biol Chem, 2005, 280(12): 11902-11910.
[31] Luo S, Rohloff P, Cox J, et al . Trypanosoma brucei plasma membrane-type Ca~(2+)-ATPasel (TbPMC1) and2 (TbPMC2) genes encode functional Ca~(2+)-ATPases localized to the acidocalcisomes and plasma membrane and essential for Ca~(2+)-homeostasis and growth. J Biol Chem, 2004, 279 (14): 14427-14439.
[32] Price HP, Panethymitaki C, Goulding D, et al. Functional analysis of TbARL1 an N-myrlstoylated Golgi protein esential for viabilityin bloodstream trypanosomes. J Cell Sci. 2005, 118 (4):831—841.
[33] Mackey ZB, O' Brien TC,Greenbaum DC, et al. A cathepsin Blike protease is required for host protein degradation in Trypanosom brucei. J Biol Chem, 2004,279(46): 48426-48433.
[34] Jensen BC, Brekken DL, Randall AC, et al. Species specificity in ribosome biogenesis: a nonconselwed pHospHoprotein is required for formation of the large ribosomal subunit in Trypanosoma brucei. Eukaryot Cell, 2005, 4(1): 30-35.
[35] Chandra Subramaniam, Paul Veazey, Seth Redmond, et al. Chromosome- Wide Analysis of Gene Function by RNA Interference in the African Trypanosome. Eukaryot Cell. 2006,5(9): 1539-1549
[36] McRobert L, McConkey GA. RNA interference (RNAi) inhibits growth of Plasmodium,falciparum.Mol Biochem Parasitol,2002,119(2):273-278.
[37]J Malhotra P,Dasaradhi PV,Kumar A,et al.Double-stranded RNA-mediated gene silencing of cysteine proteases(falcipain-1 and 2)of Plasmodium falciparum.Mol Microbiol.2002,45(5):1245-1254.
[38]Mohmmed,A.,Dasaradhi,P.V.,Bhatnagar,R.K.,Chauhan,V.S.,and Malhotra,P.In vivo gene silencing in Plasmodium berghei-a mouse malaria model.Biochem BiopHys Res Commun 2003,309:506-511.
[39]Kumar R,Adams B,Oldenburg A,et al.Characterisation and expression of a PP1 serlne/threonine protein pHuspHatase(PfPP1)from the malaria parasite,Plasmodium,nlciparum:demonstration of its essential role using RNA interference.Malar J,2002,1(1):5.
[40]Tina Rathjen,Clare Nicol,Glenn McConkey,Tamas Dalmay.Analysis of short RNAs in the malaria parasite and its red blood cell host.FEBS Letters,2006,580:5185-5188
[41]Al-Anouti F,Ananvoranich S.Comparative analysis of antisense RNA,double-stranded RNA,and delta ribozyme-mediated gene regulation in Toxoplasma gondii.Antisense Nucl Acid Drug.2002,12:275-281.
[42]Brian Adams,Alla Musiyenko,Rajinder Kumar,et al.A Novel Class of Dual-family ImmunopHilins.J.Biol.Chem.,2005 280(26):24308-24314,July 1,
[43]Vaysie L,vargaS M,Weber C,et al.Double-stranded RNA mediates homology-dependent gene silencing of gamma-tubulin in the human parasite Entamoeba histolytica.Mol Biochem Parasitol,2004,138(1):21-28.
[2]Luft BJ,Remington JS.Toxoplasmic encep Halitis in AIDS.ClinInfect Dis,1992,15(2):211-22
[3]Kasper LH,Buzoni-gatel D.Some opportunistic parasitic infectios in AIDS:candidiasis,cryptosporidiosis,toxoplasmosis.Paratitol Today,1998,14(4):150-156.
[4]Conrath J,Mouly-BandiniA,Collart F,et al.Toxoplasm gondii retino choroiditis after cardiac transplantation.Graefes Arch Clin Exp OpHthalmol,2003,241(4):334-8
[5]Mayes JT,OConnor BJ,Avery R,et al.Transmission of Toxoplasmagondii infection by liver transplantatiom Clin Infect Dis.1995,21(3):511-5
[6]AJ Cook,Gilbert RE,Buffolano W,et al.Sources of toxoplasma infection in pregnant women:European multicentre case-control study.European Research Network on Congenital Toxoplasmosis.BMJ.2000,321(7254):142-7
[7]Stommel EW,Seguin R,Thadani VM,SchwartzmanJD,Gilbert K,Ryan KA,Tosteson TD et al.Cryptogenic epilepsy:An infectious etiology?Epilepsia 2001,42:436-438
[8]YolkenRH,Bachmann S,Ruslanova I,Lillehoj E,Ford G,Torrey EF,Schroeder J.Antibodies to Toxoplasma gondii in individuals with firstepisode schizophrenia.Clin Infect Dis 2001,32:842-844 el
[9]Kouni MH.Adenosine metabolism in Toxoplasma gondii:Potential targets for chemotherapy.Curr PHarm Des 2007,13:581-597
[10]Smith AT,Tucker-Samaras SD,Fairlamb AH,Sullivan WJ Jr.MYST family histone acetytransferases in the protozoan parasite Toxoplasma gondii.Eukaryot Cell 2005,4:2057-2065
[11]Fiedler M,Horn C,Bandtlow C,et al.Anengineered IN-1 Fab fragment with improved affinity forth eNogo-Aaxonal growth inhibitor permits immunochemical detection and shows enhanced neutralizing activity.Protein Eng.2002,15,931-941.
[12]Yu JY,Taylor J,DeRuiter SL,et al.Simultaneous inhibition of GSK3alpHa and GS K3 beta usingh airpins RNAi expressionv ectors.MoL Ther,2003,7:228-236.
[13]Brosamle C,Huber AB,Fiedler M,Set al.Re-generation of lesioned corticospinal tract fibers in the adult rat in duced by a recombinant,humanized IN-1 antibody fragment.J.Neurosci.2000,20,8061-8068.
[14]Amarzguioui M,Holen T,Babaie E,etal.Tolerance for mutations and Chemical modifications in a siRNA.Nucleic Acids Res,2003,312589-595.
[15]章谷生 容秉培主编.单克隆抗体技术在医学中的应用.上海科学技术出版社 1987:13-14.
[16]Donald RG,Roos DS.Insertional mutagenesis and marker rescue in a protozoan parasite:Cloning of the uracil pHospHoribosyltransferase locus from Toxoplasma gondii.Proc Natl Acad Sci USA 1995,92:5749-5753
[17]Luo S,Marchesini N,Moreno SN,Docampo R.A plant-like vacuolar H+-pyropHospHatase in Plasmodium falciparum.FEBS Lett 1999,460:217-220
[18](美)萨姆布鲁克(sambrook,J)等著;黄培堂等译.分子克隆实验指南.第三版.北京:科学出版社,2002.8:96-98.
[19]Laemmli UK.Cleavage of structural proteins during the assembly of the head of bacteriopHage T4.Nature 1970,15:227:680-685.
[20]Hillier LD,Lennon G.,Becker M,Bonaldo MF,Chiapelli B,Chissoe S,Dietrich N et al.Generation and analysis of 280,000 human expressed sequence tags.Genome Res 1996,6:807-828
[21]Scheetz TE,Raymond MR,Nishimura DY,McClain A,Roberts C,Birkett C,Gardiner J et al.Generation of a high-density rat EST map.Genome Res 2001,11:497-502
[22]Marra MA,Kucaba TA,Hillier LW,Waterston RH.High-throughput plasmid DNA purification for 3 percents sample.Nucleic Acids Res 1999,27:e37
[23]Calvin Jungl,Cleo YF.Leel Michael,et al.The SRS superfamily of Toxoplasma surface proteins.International Journal for Parasitology 34(2004)285-296
[24]Gutierrez Escobar AJ,Gomez-Marin JE.Toxoplasma gondii:Identification of a putative nitric oxide synthase motif DNA sequence.Exp Parasitol 2005,111:211-218
[25]Ajioka JW,Boothroyd JC,Brunk BP,Hehl A,Hillier L,Manger ID,Marra M et al.Gene discovery by EST sequencing in Toxoplasma gondii reveals sequences restricted to the Apicomplexa.Genome Res 1998,8:18-28
[26]Escobar AJ,Arenas AF,Gomez-Marin JE.Molecular evolution of serine/arginine splicing factors family(SR)by positive selection.In Silico Biol 2006,6:347-350
[27]凌家俭,章子豪,张耀娟卫氏并殖吸虫成虫cDNA文库的单抗筛选[J].中国人兽共患病杂志,2002 18(3):48-51.
[28]Mercier E,Lecordier L,Darcy F,Deslee D,et al.Molecular characterization of a dense granule antigen(Gra 2)associated with the network of the parasitopHorous vacuole in Toxoplasma gondii[J].Mol Biochem Parasitol 1993;58(1):71-82
[29]Ahn H J,Kim S,Nam HW.Molecular cloning of the 82-kDa heat short protein(HSP90)of Toxoplasma gondii associated with the entry into and growth in host cells.Biochem BiopHys Res Commun 2003,311:654-659
[30]Ahn H J,Kim S,Nam HW.Molecular cloning of a rhoptry protein(ROP6)secreted from Toxoplasma gondii.Korean J Parasitol 2006,44:251-254
[31]M.F.CESBRON-DELAUW,B.Guyt,G.TORPIER,R.J.PIERCE,et al.Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii(cDNA cloning/Ca2+-binding protein).Proc.Natl.Acad.Sci.USA Vol.86,pp.7537-7541,October 198
[32]Parmley SF,Yang S,Harth G,et al.Molecular characterization of a 65-kilodalton Toxoplasma gondii antigen expressed abundantly in the matrix of tissue cysts J.Mol Biochem parasitol,1994,66(2):283-296.
[33]Nockemann S,Dlugonska H,Henrich B.Expression,characterization and serological reactivity of a 41kDa excreted-secreted antigen (ESA)from Toxoplasma gondii.[J].Mol Biochem parasitol,1998, 97(1-2):109-121.
[34]Ossorio PN,Schwartzman JD,Boothroyd JC.A Toxoplasma gondii rhoptry protein associated with host cell penetration has unusual charge asymmetry.Mol Biochem Parasitol 1992,50:1-15
[35]Kimberly L.Carey,Carolyn G.Donahue,Gary E.Ward.Identification and molecular characterization of GRA8,a novel,proline-rich,dense granule protein of Toxoplasma gondii_Molecular and Biochemical Parasitology 2000,105:25-37
[36]Bohne W,Gross U,Ferguson DJ,Heesemann J.Cloning and characterization of a bradyzoite-specifically expressed gene(hsp30/bag1)of Toxoplasma gondii,related to genes encoding small heat-shock proteins of plants.Mol Microbiol 1995,16:1221-1230
[37]Li L,Brunk BP,Kissinger JC,Pape D,Tang K,Cole RH,Martin J et al.Gene discovery in the apicomplexa as revealed by EST sequencing and assembly of a comparative gene database.Genome Res 2003,13:443-454
[38]Kami Kima B,Louis M.Weissa,C.Toxoplasma gondii:the model apicomplexan.International Journal for Parasitology,2004,34423-432.
[39]熊思东,徐薇.DNA疫苗的研究进展.中国处方药,2003,2:35237.
[40]Hoffman SL,Sedegah M,Hedstrom RC.Protection against malaria by immunization with a Plasmodium yoelii circumsporo zoite protein nucleic acid vaccine.Vaccine,1994,12(16):15292-1533
[41]Damo X,Lien FX.Genetic vaccination against leishmania.Vaccine,1994,12:1534-6.
[42]Angus CW.Nucleic acid vaccination against Toxoplasma gondii in mice.J Eudaryot Microbiol,1996,43(5):1172118.
[43]Xu D,Liew FY.Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein,gp63 of L.major.Immunology 1995,84:173-6.
[44]Rafati S,Salmanian AH,Taheri T,et al.A protective cocktail vaccine against murine cutaneous Leishmania major.Vaccine.2001,19:3369-75.
[45]Alberti E,Acosta A,Sarmiento ME.et al.Specific cellular and humoral immune response in BALB/c mice immunised with an expression genomic library of Trypanosoma cruzi.Vaccine.1998,16:608-12.
[46]Sepulveda P,Hontebeyrei M,Liegeard P,Mascilli A,Norris KA.DNA-based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection.Infect Immun 2000,68:4986-91.
[47]Amador EA,Acosta Dominguez A,Sarmineto ME,Hidalgo Grass C,Fachado Carvajales A,Vidal Martinez T,et al.Specific humoral response in BALB/c mice inoculated with genome library of expression of Trypanosoma cruzi.Rev Cuba Med Trop 1999;51:20-5.
[48]Mendez S,Gurunathan S,Kamhawai S,et al.The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose,intradermal challenge.J Immunol 2001;166:5122-8.
[49]Angus CW,Klivington-Evans D,Dubey JP,and Kovacs J A.Immunization with a DNA plasmid encoding the SAG1(P30)protein ofToxoplasma gondii is immunogenic and protective in rodents.J.Infect.Dis.2000,181:317-324.
[50]Nielsen HV,Lauemoller S L,Christiansen L,et al.Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene.Infect.Immun.1999.67:6358-6363.
[51]Beghetto,E.,A.Pucci,O.Minenkova,et al.Identification of a human immunodominant B-cell epitope within the GRA1 antigen of Toxoplasma gondii by pHage display of cDNA libraries.Int.J.Parasitol.2001.31:1659-1668.
[52]Cesbron-Delauw MF,Guy B,Torpier G,et al.Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii.Proc.Natl.Acad.Sci.USA 1989,86:7537-7541.
[53]Duquesne V,Auriault C,Gras-Masse H,et al.Identification of T cellepitopes within a 23-kD antigen(P24)of Toxoplasma gondii.Clin.Exp.Immunol.1991.84:527-534.
[54]Desolme B,M.N.Mevelec,D.Buzoni-Gatel,and D.Bout.Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene.Vaccine.2000, 18:2512-2521.
[55]Guo,H.,G.Chen,F.Lu,H.Chen,and H.Zheng.Immunity induced by DNA vaccine of plasmid encoding the rhoptry protein 1 gene combined with the genetic adjuvant of pcIFN-gamma against Toxoplasma gondii in mice.Chin.Med.J.(Engl.Ed.)2001,114:317-320.
[56]Leyva,R.,P.Herion,and R.Saavedra.Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii.Parasitol.Res.2001,87:70-79.
[57]Vercammen,M,Scorza T,Huygen K,De Braekeleer,Diet R,Jacobs D,Saman E,and Verschueren H.DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1,GRA7,and ROP2 induces partially protective immunity against lethal challenge in mice.Infect.Immun.2000,68:38-45.
[58]Angus CW,Clivington-Evans D,Dubey JP,et al.Nucleic acid vaccination against Toxoplasma gondii in mice.J.Eudaryot Microbiol,1996,43(5):117-118
[59]Nielsen HV,Lauemoller SL,Christiansen L,et al.Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene.InfectImmun,1999,67:635826363.
[60]Bout D.Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles:preparation,characterization,and preliminary i n vivo studies.Int J PHarmaceutics,2003,266(122):17227.
[61]Desolme B,Marie2Noelle M,Buzoni2Gatel D,et al.Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene.Vaccine,2000,18:251222521.
[62]Vercammen M,Scorza T,Huygen K,et al.DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1,GRA7 and ROP2 induces partially protective immunity against lethal challenge in mice.Infect Immun,2000,68:38245.
[63]Fachado A,Rodriguez A,Angel SO,et al.Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice.Vaccine,2003,21(13214):132721335.
[64]Mohamed RM,Aosai F,Chen M,et al.Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70,HSP30and SAG1 genes.Vaccine,2003,21(21222):285222861.
[65]Suzuki Y,Rani S,Oliver L.Imparied resistance to the development of Toxoplasmic:EncepHalitis in interleukin 6-deficient mice.[J]Induct Immun,1997,65(6):2339-2349
[66]Lloyol HK,Mastsuura T,Finseka S.Induction of γ δTcell during acute murine infection with Toxoplasma gondii.J Immunol,1996,157(12):5521-5527
[67]Nagasawa H,Hisaeda H,Maelawa Y,et al.Gama delta Tcells play crucial role in the expression of 65,000MW heat-shock protein in mice innunized with Toxoplasma antigen.J.Immunol,1994,83(3):347-352.
[68]Suzuki Y,Remington JS.The effect of anti-IFN-γ antibody in the protective effect of Lyt2+T cell against Toxoplasmasis in mice.J Immunol,1990,144(5):1954-1956
[69]Suzuki Y,Orellana MA,Sxhreiber RD.Interferon-gama:The major mediater of resistance against Toxoplasma gondii.Science,1988,240(4851):516-518.
[70]Suzuki Y,Conley FK,Remington JS.Importance of endogenacs IFN-γfor prevention of Toxoplasmic EncepHalitis in mice.J Immunol,1989,143(6):2045-2050.
[71]Donnelly JJ,Ulmer JB,Shiver JW,Liu MA.DNA vaccines.AnnuRev Immunol 1997,15:617-48.
[72]Stacey KJ,Blackwell JM.Immunostimulatory DNA as an adjuvantin vaccination against Leishmania major.Infect Immunol 1999,67:3719-26.
[73]Kowalczyk DW,Ertl HC.Immune responses to DNA vaccines.CellMol Life Sci 1999,55:751-70.
[74]Gazzinelli RT,Hakin FT,Hieny S,Shearer GMA,Sher A.Synergistic role of ED4+ and CD8+ T lympHocytes in IFN-gamma productionand protective immunity induced by an attenuated T.gondii vaccine.J Immunol 1991,146:286-92.
[75]Gazzinelli RT,Hieny S,Wynn TA,Wolf S,Sher A.Interleukin-12 is required for the T-lympHocyte-independent induction to interferon gamma by an intracellular parasite and induces resistance in T cell deficient host.Proc Natl Acad Sci USA 1993,90:6115-9.
[76]Todryk S,Melcher AA,Dalgleish AG,et al.Heat shock proteins refine the danger theory.Immunology 2000,99:334- 7.
[77]Tighe H,Corr M,Roman M,Raz E.Gene vaccination:plasmid DNA is more than just a blueprint.Immunol Today 1998,19(2):89-97.
[78]Kevin N.Couper,Henrik V.Nielsen,Eskild Petersen,Fiona Roberts,Craig W.Roberts,James Alexander.DNA vaccination with the immunodominant tachyzoite surface antigen(SAG-1)protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmissionVaccine 21(2003)2813-2820
[79]Nielsen HV,Lauemoller SL,Christiansen L,et al.Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG-1 gene.Infect Immun 1999,67:6358-63.
[80]Angus CW,Klivington-Evans D,Dubey JP,Kovacs JA.Immunization with a DNA plasmid encoding the SAG-1(P30)protein of Toxoplasma gondii is immunogenic and protective in rodents.J Infect Dis.2000;181:317 -24.
[81]Vercammen M,Scorza T,Huygen K,De Braekeleer J,Diet R,Jacobs D,et al.DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1,GRA7,and ROP2 induces partially protective immunity against lethal challenge in mice.Infect Immun.2000,68:38-45.
[82]Desolme B,Mevelec M-N,Buzoni-Gatel D,Bout D.Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene.Vaccine 2000,18:2512 -21.
[83]T.Scorza,S.D' Souza,M.Laloup,J.Dewit,J.De Braekeleer,H.Verschueren,M.Vercammen,K.Huygen,and E.Jongert.A GRA1 DNA Vaccine Primes Cytolytic CD8_ T Cells To Control Acute Toxoplasma gondii InfectionINFECTION AND IMMUNITY,Jan.2003,p.309-316
[84]Napoli C,Lemieux C,Jorgensen R.Introduction of achalcone synthase gene in to Petuinia results in reversible co-suppression of homologous genes in trans.Plant Cell,1990;2(4):2 79
[85]Fire A,Xu S,Montgmery MK,et at.Potent and specific geneticinterference by double-stranded RNA in Caenorhabditis elegans.Nature,1998,391:806-811.
[86]Guo S,KempHuesK J.Par-1,a genere quired for establishing polarity in C.elegans embryos,encodes a putative Ser/Thrkinase that is asymmetrically distributed.Cell,1995;81(4),611
[87]Beckebaum S,Cicinnati VR,Dworacki G,et al.Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DCI in chronic hepatitis B infection.Clin Immunol,2002,104(2):138-150
[88]Greenberg HB,Pollard RB,Lutwick LI,et al.Efect of human leukocyte Interferon on hepatitisB virusin fection in patients with chronic active hepatitis.N.EnglJ.Med,1976,295(10):517-522
[89]Wong DKH,Cheung AM,O'Rourke K,et al.Efect of alpHa-in-terferon Treatment in patients with hepatitis Be antigen-positivec hronich epatitisB.Ann Intern Med,1993,119:312
[90]Lin SM,Sheen IS,Chien RN,et al.Long-term beneficial dfect of interferon the rapyin patients with chronich epatitisB virusin fection.Hepatology,1999,29(3):971-975
[91]MosmannT R,CherwinskiH,BondM W,et al.Two types of murine helperT-cell Clone.I Definition according to profile so flymp-Hokine activities and secreted proteins.J Immunol,1986,136(7):2348-2357
[92]Niederau C,Heintges T,Lange S,et al.Long-term follow-up of HbeAg-positive Patients treated with interfereon alfa for chronich epatitisB.N EnglJ M ed,1996,334(22):1422-1427
[93]Torre D,Tambini R.In terferon-alpHath erapyfo rch ronich epatitis B in children:A meta-analysis.C linIn fectD is,1996,23(1):131-137
[94]Hadziyannis s S,B ramouT,M akris A,etal.In terferon alfa-2b treatment If HbeAg negative serum HBV DNA positive chronic activeh epatitsB.J Hepatol,1990,11(Supp 11):S133-S136
[95]Pastore G,Sa ntantonio T,M ilella A,et al.Anti-HBe-positive chronic hepatitisB with HBV-DNA in the serum:responesto a 6 month course of lympHoblastoidinterferon.Jhepatol,1992,14(2-3):221-225
[96]Cooksley WGE,Lai MY,Wang YJ,et al.HBeAg-positive chronic Hepatitis B (CHB) patients with difcult-to-treat disease: improved response rates with Peg interferonAlfa-2A (40KD) (PEGASYS) compared with conventional interferon Alfa-2a.Hepatology,2002,36(4) :374A
[97] Fattovichq Farci P; Rugge M, et al. Arandomized controlled trial of lympHobalastoid interferon-alfa in patients with chronic hepatitisB lacking HbeAg. Hepatology, 1992,15(4):584-589
[98] Lampertico P, DelN innoE, manzinA , et al .Arandomized, controlled trial of a 24-month couse of interferon alfa2b in patients with chronic hepatitisB who had Hepatitis B virusDNA without be patitisBe antigen in serum. Hepatology, 1997, 26(6): 1621—1625
[99] Cooksley WGE, Piratvisuth T, Lee SD, et al. Peginterferon a-2a (40kDa): an Advance in the treatment of hepatitis Be antigen-positive chronic hepatitisB .J Viral Hepat, 2003,10(4):298-305
[100] Thijn R. Brummel kamp, Rene Bernards, Reuven Agami1.A System for Stable Expression of Short Interfering RNAs in Mammalian Cells. SCIENCE 19 APRIL 2002, VOL 550: 296
[101] Thijn R. Brummelkamp, Rene Bernards, and Reuven Agami. Stable suppression of tumorigenicity by virus-mediated RNA interference. CANCER CELL AUGUST 2002,22.
[102] J. Y. Yu, S. L. Deruiter, D. L. Turner. RNA interference by expression of short -interfering RNAs and hairpin RNAs in mammalian cells. PNAS, 2002,99:6047-6052.
[103] Shen C, Buck A K, Liu X, et al. Gene silencing by adeovirus-delivered siRNA. FEBS, 2003, 539:111-114
[104] Ullu E, Tschudi C, Chakraborty T. RNA interference in protozoan parasites.Cell Microbiol. 2004.6, 509 - 519.
[105] Ahmad Al Riyahi, Fatme Al-Anouti, Marwan Al-Rayes, Sirinart AnanvoranichInternational Single argonaute protein from Toxoplasma gondii is involved in the double-tranded RNA induced gene silencing Journal for Parasitology. 2006, 36:1003-1014
[106] Al-Anouti F and Ananvoranich S. Comparative analysis of antisense RNA, double-stranded RNA, and delta ribozyme-mediated gene regulation in Toxoplasma gondii. Antisense Nucl Acid Drug. 2002,12:275-281.
[107] Al-Anouti, F., Quach, T. & Ananvoranich, S. Double-stranded RNA can mediate the suppression of uracil pHospHoribosyltransferase expression in Toxoplasma gondii.Biochem.BiopHys.Res.Commun.2003,02:316-323.
[108]Brian Adams,Alla Musiyenko,Rajinder Kumar,and Sailen Barik.A Novel Class of Dual-family ImmunopHilins J.Biol.Chem.,2005,280(26):24308-24314,July 1,
[109]Sirinart ananvoranich,Marian AL Rayes,Ahmad Al Riyahi and Xiang Wang.RNA Silencing of Glycolysis Pathway in Toroplasma gondii.Eukaryot.Microbiol.2006,3(S1),pp.S162-S163
[110]宋尔卫.DNA干扰的生物学原理与应用。北京:高等教育出版社.第一版.2005.1-30.
[111]G.J.汉农.RNAi基因沉默指南.北京:化学工业出版社.第一版.2004.86-105.
[112]Ute Schepers.实用RNAi技术-线虫、果蝇和哺乳动物细胞基因沉默的基本原则与方法.北京:人民卫生出版社.第一版.2006.58-78.
[113]Soldti D,Boothroyd JC.Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii.Science.1993,60(5106):349-52.
[114]Lindscry DS,Pinto DC,Yila I,et al.Safety and result of challenge of weaned pigs given a temperature sensitive mutant of Toxoma gondii.Parasitology.1993,79(1):71272.
[115]Gazzinelli RT,Hakim FT,Hieny S,et al.Synergistic role of CD4+ and CD8+T lympHocytes in IFN2c production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.J.Immunol.1991,146:2862292.
[116]O' connell E.Toxoplasmosis in sheep Ⅱ the ability of a live vaccine to prevent lamb losses after an intravenous challenge with Toxoplasma gondii.New Zealand Vet.J,1988,36:122.
[117]Buxton D,Innes E A.A commercial vaccine for ovine toxoplasmosis.Parasitology,1995,110(1):11216.
[1]Fire A,Xu S,Montgmery M K,et al.Potent and specific geneticinterference by double-stranded RNA in Caenorhabditis elegans.Nature,1998,391:806-811.
[2]Zamore PD,Tuschl T,Sharp PA,et al.RNAi:double stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals.Cel,2000,101(1):25-33.
[3]Kasschau KD,Carrington JC.A counterdefensive strate of plant viruses:uppression of posttranscriptional gene silencing.Cell,1998,95(4):461-470.
[4] Brigham PM. Cosuppression comes to the animals. Cell, 1997, 90(3): 385-387.
[5] Tuschl T, Zalnore PD, I_ehraann R, et al. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev, 199913(24): 3191—3197.
[6] Tavemarakis N, Wang S L, Domvkov M et al. Heritable and inducible genetic interference by double-stranded RNA encoded by trims genes. Nature Genetics, 2000; 24: 180-183.
[7] Lipardi C, Wei Q, Paterson BM RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. CAI, 2001,107: 297—307.
[8] Brummelkamp TR, Bernards R, Agni R. A system for stable expresion of short interfering RNAs in mammaliancells. Science, 2002,296(5 567): 550-553.
[9] Hutvagner G. Small RNA asymmetry in RNAi: Function in RISC assembly and gene regulation. FEBS Lett, 2005, [Epub ahead of print].
[10] Retting RF, Fischer SE, Bernstein E, et al. Dicer functionsin RNA interference and in synthesis of small RNA involved indevelopment altiming in C. elegans. Genes Dev, 2001,15(20): 2654-2 659.
[11] Harmon GJ. RNA interference. Nature, 2002, 418(6 894): 244-251.
[12] Meister G, Tuschi T. Mechanisms of gene silencing by double-stranded RNA. Nature, 2004, 431(7 006): 343—349.
[13] j wu Scharf D, Jeong B, Zhang C, et al. Transgene and transposon silencing in Chiamydomonas reinhardtii by a DEAH-box RNA helicase. Science, 2000, 290(5 494): 1159-1162.
[14] Melo CC, Conte D Jr. Revealing the world of RNA interference. Nature, 2001,4, 431(7 006): 338-342.
[15] David P. Knoxl, Peter Geldhof2, Aline Visser2 and Collette Britton.RNA interference in parasiticnematodes of animals: a reality check? TRENDS in Parasitology 2007, 23(3):105-107
[16] Ayman S. Hussein, Ketty Kichenin, Murray E. Selkirk. Suppression of secreted acetylcholinesterase expression inNippostrongylus brasiliensis by RNA interference . Molecular Biochemical Parasitology. 2002, 122: 91-94
[17] Aziz Aboobaker and Mark L Blaxter. Use of RNA interference to investigate gene function in the human filarial nematode parasite Brugia malayi.Mol Biochem Parasitology,2003,129(1):41-51
[18]Sara Lustigman,Jun Zhang,Jing Liu,Yelena Oksov and Sarwar Hashmi.RNA interference targeting cathepsin L and Z-like cysteine proteases of Onchocerca volvulus confirmed their essential function during L3 molting.Mol Biochem Parasitology,2004,138(2):165-170
[19]Patrick J.Skelly,Akram Da' dara,Donald A.Harn Suppression of cathepsin B expression in Schistosoma mansoni by RNAinterference.International Journal for Parasitology.2003,33:363-369
[20]Ahmed Osman,Edward G Niles,Sergio Verjovski-Almeida,and PHilip T,LoVerde.Schistosoma mansoni TGF-β Receptor Ⅱ:Role in Host Ligand-Induced Regulation of a Schistosome Target Gene.PLoS Pathog.2006,2(6):e54
[21]Yuemei Dong,Harry E Taylor,and George Dimopoulos.AgDscam,a Hypervariable Immunoglobulin Domain-Containing Receptor of the AnopHeles gambiae Innate Immune System.PLoS Biol.2006;4(7):229.
[22]Yuemei Dong,Ruth Aguilar,Zhiyong Xi,Emma Warr,Emmanuel Mongin2,George.DimopoulosAnopHeles gambiae Immune Responsesto Human and Rodent Plasmodium.Parasite Species.PLoS Pathog 2006,2(6):513-525
[23]Elisabetta Ullu,Christian Tschudi and Tirtha Chakraborty.RNA interference in protozoan parasites.Cellular Microbiology 2004,6(6):509-519
[24]Shi H,Djikeng A,Tschudi,C.,and Ullu,E.Argonaute protein in the early divergent eukaryote Trypanosoma brucei:control of small interfering RNA accumulation and retroposon transcript abundance.Mol Cell Biol 2004,24:420-427.
[25]Huynh TT,Huynh vT,Harmon MA,etal.Gene knockdown of gamma glutamylcysteine synthetase by RNAi in the parasitic protozoa Trypanosoma brucei demonstrates that it is an essential enzyme.J Biol Chem,2003,278(41):39794-39800.
[26]Wilkinson SR,Horn D,Prathalingam SR,et al.RNA interferenceidentifies two hydroperoxide metabolizing enzym es that are essential to the bloodstream form of the african trypanosome.J Biol Chem,2003,278(34): 31640—31646.
[27] Comini MA, Guerrero SA, Haile S, et al. Valdiation of Try. panosoma brucei trypanothione synthetase as drug target. Free Radic Biol Med, 2004, 36(10): 1289—1302.
[28] CoustouV, Besteiro S, Riviere L, et al. Amitochondrial NADH-dependent fumarate red uctase involved in the production of succinate excreted by procyclic Trypanosoma brucei. J Biol Chem, 2005,280(17): 16559— 16570
[29] Kesler PS, Parsons M、 Probing the role of compartmentation of glycolysis in procyclic forlTI Try panosoma bruce: RNA interference studies of PEX1, hexokinase, and pHospHofructokinase. J Biol Chem, 2005, 280(10): 9030—5036.
[30] Lamour N, Riviere L, Coustou V, et al、 Proline metabolism in procyclic Trypanosoma brucei is down regulated in the presence of glucose. J Biol Chem, 2005, 280(12): 11902-11910.
[31] Luo S, Rohloff P, Cox J, et al . Trypanosoma brucei plasma membrane-type Ca~(2+)-ATPasel (TbPMC1) and2 (TbPMC2) genes encode functional Ca~(2+)-ATPases localized to the acidocalcisomes and plasma membrane and essential for Ca~(2+)-homeostasis and growth. J Biol Chem, 2004, 279 (14): 14427-14439.
[32] Price HP, Panethymitaki C, Goulding D, et al. Functional analysis of TbARL1 an N-myrlstoylated Golgi protein esential for viabilityin bloodstream trypanosomes. J Cell Sci. 2005, 118 (4):831—841.
[33] Mackey ZB, O' Brien TC,Greenbaum DC, et al. A cathepsin Blike protease is required for host protein degradation in Trypanosom brucei. J Biol Chem, 2004,279(46): 48426-48433.
[34] Jensen BC, Brekken DL, Randall AC, et al. Species specificity in ribosome biogenesis: a nonconselwed pHospHoprotein is required for formation of the large ribosomal subunit in Trypanosoma brucei. Eukaryot Cell, 2005, 4(1): 30-35.
[35] Chandra Subramaniam, Paul Veazey, Seth Redmond, et al. Chromosome- Wide Analysis of Gene Function by RNA Interference in the African Trypanosome. Eukaryot Cell. 2006,5(9): 1539-1549
[36] McRobert L, McConkey GA. RNA interference (RNAi) inhibits growth of Plasmodium,falciparum.Mol Biochem Parasitol,2002,119(2):273-278.
[37]J Malhotra P,Dasaradhi PV,Kumar A,et al.Double-stranded RNA-mediated gene silencing of cysteine proteases(falcipain-1 and 2)of Plasmodium falciparum.Mol Microbiol.2002,45(5):1245-1254.
[38]Mohmmed,A.,Dasaradhi,P.V.,Bhatnagar,R.K.,Chauhan,V.S.,and Malhotra,P.In vivo gene silencing in Plasmodium berghei-a mouse malaria model.Biochem BiopHys Res Commun 2003,309:506-511.
[39]Kumar R,Adams B,Oldenburg A,et al.Characterisation and expression of a PP1 serlne/threonine protein pHuspHatase(PfPP1)from the malaria parasite,Plasmodium,nlciparum:demonstration of its essential role using RNA interference.Malar J,2002,1(1):5.
[40]Tina Rathjen,Clare Nicol,Glenn McConkey,Tamas Dalmay.Analysis of short RNAs in the malaria parasite and its red blood cell host.FEBS Letters,2006,580:5185-5188
[41]Al-Anouti F,Ananvoranich S.Comparative analysis of antisense RNA,double-stranded RNA,and delta ribozyme-mediated gene regulation in Toxoplasma gondii.Antisense Nucl Acid Drug.2002,12:275-281.
[42]Brian Adams,Alla Musiyenko,Rajinder Kumar,et al.A Novel Class of Dual-family ImmunopHilins.J.Biol.Chem.,2005 280(26):24308-24314,July 1,
[43]Vaysie L,vargaS M,Weber C,et al.Double-stranded RNA mediates homology-dependent gene silencing of gamma-tubulin in the human parasite Entamoeba histolytica.Mol Biochem Parasitol,2004,138(1):21-28.